Ketone bodies inhibit the viability of human neuroblastoma cells

Journal of Pediatric Surgery

Volumn 44, Issue 1, 2009, Pages 212-216

  Skinner, Robert ^a   Trujillo, Angelica ^a   Ma, Xiaojie ^a   Beierle, Elizabeth A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Hydroxybutyrate; Acetoacetate; Ketone bodies; Neuroblastoma; Pediatric; SCOT

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 OXOACID COENZYME A TRANSFERASE; ACETOACETIC ACID; BETA ACTIN; GLUCOSE; HYDROXYBUTYRIC ACID; KETONE BODY;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENERGY RESOURCE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACYL COENZYME A; ANALYSIS OF VARIANCE; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; KETONE BODIES; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 58149514084     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.10.042     Document Type: Article

References (18)

1. Cotterill S.J., Parker L., More L., et al. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry. Med Pediatr Oncol 36 (2001) 231-234
2. Greene A.E., Todorova M.M., and Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 86 (2003) 529-587
3. Mies G., Paschen W., Ebhardt G., et al. Relationship between blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally induced glioma (RG1 2.2) of rat brain. J Neurooncol 9 (1990) 17-28
4. Mangiardi J.R., and Yodice P. Metabolism of the malignant astrocytoma. Neurosurg 26 (1990) 1-19
5. Roslin M., Henriksson R., Bergstrom P., et al. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 61 (2003) 151-160
6. Oudard S., Boitier E., Miccoli L., et al. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. Anticancer Res 17 (1997) 1903-1911
7. Sawai M., Yashiro M., Nishiguchi Y., et al. Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA:3-oxoacid CoA-transferase (SCOT) deficiency. Anticancer Res 24 (2004) 2213-2217
8. Noh H.S., Hah Y.S., Nilufar R., et al. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neuroscience Res 83 (2006) 702-709
9. Beierle E.A., Trujillo A., Nagaram A., et al. N-myc regulates focal adhesion kinase expression in human neuroblastoma. J Biol Chem 282 (2007) 12503-12516
10. Nebeling L.C., Miraldi F., Shurin S.B., et al. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 14 (1995) 202-208
11. Zhou W., Mukerjee P., Kiebish M.A., et al. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab 4 (2007) 1-15
12. Fearon K.C., Borland W., Preston T., et al. Cancer cachexia: influences of systemic ketosis on substrate levels and nitrogen metabolism. Am J Clin Nutr 47 (1988) 42-48
13. Snyderman S.E., Sansaricq C., and Middleton B. Succinyl-CoA:3-ketoacid CoA-transferase deficiency. Pediatrics 101 (1998) 709-711
14. Fenselau A., Wallis K., and Morris H.P. Acetoacetate coenzyme transferase activity in rat hepatomas. Cancer Res 35 (1975) 2315-2320
15. Fredericks M., and Ramsey R.B. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. J Neurochem 31 (1978) 1529-1531
16. Berthold F., Trechow R., Utsch S., et al. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 14 (1992) 207-215
17. Berthold F., Kassenbohmner R., and Zieschang J. Multivariate evaluation of prognostic factors in neuroblastoma. Am J Pediatr Hematol Oncol 16 (1994) 107-115
18. Owen O.E., Morgan A.P., Kemp H.G., et al. Brain metabolism during fasting. J Clin Invest 46 (1967) 1589-1595